Member Info for TorquayFan

And GF, IMO most LTH would think the lack of newsflow odd. Maybe the better question is, who doesn't think it's odd? And we're coming to the end of Week 7 overdue . . . That's it. GNA

GF - answer to your opening question is I'd guess - yes. It's odd !
Busy - maybe busy on holiday and why not ? In a well organised Company people can go on holiday and not everything stops ? Nil desperandum - all will be revealed . .
We do know we are coming to overdue Week 7 for SCIB 1 Combo commencement.
Come on Scancell. GLA

Yes 7 years ! Lotta water under the bridge in that time . . .
We were all pretty bouncy that day and so was the SP I believe !
Moditope into trial HI 2020 ?

Spot on DA, the SCIB 1 Combo trial is overdue - I can't see how that can be disputed. Long promised for commencement H1 we are now in H2 W7 and have not been advised of commencement. Never mind, I'm sure the Team are doing all they can and we can hope for good news soon. ATB

Well done DA - not done yet then ? GLA

Thanks that's interesting - was that PhD in Cancer Chemo before her work on the 'Holy Grail' vaccine which Crumbs kindly reminded us of recently ? Maybe what she learned about Chemo inspired Prof. Lindy to new horizons ?

https://www.dailymail.co.uk/health/article-1278836/Holy-Grail-cancer-vaccine-blasts-tumours-weeks-hailed-huge-leap-fighting-disease.html

"I have chosen to filter two posters" - how then can you be sure of what IS being posted?

"one poster from ADVFN is backing him up, or should I suggest mixing it up" - who's that then? Not me I guess as I'm filtered and also I note, LSE posts 5766, ADVFN posts 533.

Nice day all with news and blues !!

Thanks Inan. Let's hope for news of OUR combo, today or later in this Week 7 of H2.
So much going on isn't there ?

I'll expand as much as you like - FUNDING is a real and everpresent problem for Scancell, (but of course, not Scancell alone among BioTechs). K mentioned it when most, including me, didn't want to think about it, before the last 'round' that is, and he has been badgered ever since . .

And RW still hasn't finished those lines and you please get to Plainmoor Tuesday.

I know you won't mind me saying this - you have been having some fun with these Guys this weekend. A bit like Inan elsewhere - it felt a bit mischievous to me but anyway you deserve to be heard politely - your point is real. I understand from 'on high', you are trying to get approval elsewhere. Someone is having a laugh surely.

Ray - I think what you are missing is, whose heels exactly they were, disappearing and where they were going. For a Man like you Ray, who gets the science and football so much - shame on you - no matter how many recs. Shocking.

The depths to which this BB about Scancell has descended are clear.

But I think CFC will beat Man Utd tonight.

I have reported your post - snide abuse, But clever.

Yea yea yea I know -7.5 pence and worth much more. You're not wrong.
Repeat - "This endless sniding about what Folks bought or didn't is silly."

It's K.O. !!

Worthless stuff - clever but no position except WING . .

Well someone is on the wind-up - get that. Elsewhere it happens to no effect.
It's 10 minutes to EPL day 3 K.O. ATB

FWIW - I have a problem - when I 'rec' I get TWO - sun - righteous LOL Have fun Guys.

Thanks. Good to know you're you ! ATB

" "A new nano-vaccine is showing promising results in treating skin cancer in mouse models. Developed by scientists at Tel Aviv University, the prospective vaccine encases two experimental new cancer drugs inside a tiny nanoparticle, with initial experiments revealing the therapy can both stimulate the immune system to kill melanoma, and act as a preventative vaccine stopping the cancer from developing in the first place." "

https://newatlas.com/nanoparticle-cancer-vaccine-melanoma-skin-cancer/60913/

Re. funding . . . . again. Going back many many months when you were the first to highlight the funding horizon on this BB, I did feel you were roughly treated on the point. But reading yesterday's BB, it seems to me now that there are far more Posters fully aware that funding is an ongoing and everpresent issue, in the absence of deals.

You mentioned about Inan / GF123 - do you have any evidence in support ? I've noticed GF seems to have a different style these days and doesn't seem to contribute as he did before.

Anyway nice day all and blue next week please !

Getting closer to home ?

''Merck & Co/MSD’s Keytruda can be provided via the Cancer Drugs Fund for first-line treatment of non-small cell lung cancer (NSCLC) as part of a regimen with chemotherapy, says NICE. Draft guidance published today by the cost-effectiveness watchdog says that a regimen based on the checkpoint inhibitor plus carboplatin and paclitaxel should now be a treatment option for previously-untreated adults with squamous NSCLC that has spread to other parts of the body. NICE stopped short of approving it for routine NHS prescribing, but acknowledged that trials of Keytruda (pembrolizumab) plus chemotherapy suggest people taking the regimen could live longer than those who have standard chemotherapy alone.

The clinical evidence is however immature, it says, and that means the cost-effectiveness estimates for the combination are “very uncertain,” according to NICE. Keytruda and chemotherapy should be stopped after two years of uninterrupted treatment, or earlier if disease progresses, says the draft guidance.''

https://pharmaphorum.com/news/msds-keytruda-plus-chemo-backed-by-nice-for-lung-cancer/?